Primary |
Product Used For Unknown Indication |
36.4% |
Drug Use For Unknown Indication |
22.7% |
Convulsion |
18.2% |
Acquired Immunodeficiency Syndrome |
13.6% |
Folate Deficiency |
4.5% |
Surgery |
4.5% |
|
Drug Level Below Therapeutic |
28.6% |
Dizziness |
14.3% |
Medication Error |
14.3% |
Multi-organ Failure |
14.3% |
Parkinson's Disease |
14.3% |
Stupor |
14.3% |
|
Secondary |
Drug Use For Unknown Indication |
15.9% |
Tuberculosis |
15.4% |
Hypertension |
11.9% |
Product Used For Unknown Indication |
8.8% |
Convulsion |
8.5% |
Renal Transplant |
8.2% |
Breast Cancer |
6.6% |
Hepatitis B |
5.6% |
Pulmonary Tuberculosis |
3.7% |
Hyperlipidaemia |
3.4% |
Status Epilepticus |
2.4% |
Epilepsy |
1.6% |
Accidental Exposure |
1.3% |
Myoclonic Epilepsy |
1.3% |
Prophylaxis |
1.3% |
Diabetes Mellitus |
1.1% |
Antibiotic Prophylaxis |
0.8% |
Eye Infection Toxoplasmal |
0.8% |
Peripheral Vascular Disorder |
0.8% |
Colon Cancer |
0.5% |
|
Spermatozoa Progressive Motility Decreased |
27.7% |
Spermatozoa Progressive Motility Abnormal |
17.0% |
Hepatotoxicity |
8.5% |
Drug Rash With Eosinophilia And Systemic Symptoms |
6.4% |
Hyperglycaemia |
4.3% |
Suicidal Ideation |
4.3% |
Vomiting |
4.3% |
Accidental Exposure |
2.1% |
Acute Tonsillitis |
2.1% |
Ammonia Increased |
2.1% |
Arthropod Sting |
2.1% |
Coronary Artery Stenosis |
2.1% |
Creutzfeldt-jakob Disease |
2.1% |
Dehydration |
2.1% |
Dermatitis Contact |
2.1% |
Drug Ineffective |
2.1% |
Drug Level Below Therapeutic |
2.1% |
Drug Resistance |
2.1% |
Haematoma |
2.1% |
Hypersensitivity |
2.1% |
|
Concomitant |
Product Used For Unknown Indication |
26.4% |
Drug Use For Unknown Indication |
21.9% |
Prophylaxis |
6.3% |
Hiv Infection |
6.1% |
Rheumatoid Arthritis |
5.1% |
Pain |
4.8% |
Multiple Myeloma |
4.5% |
Tuberculosis |
4.0% |
Hypertension |
3.0% |
Depression |
2.1% |
Pulmonary Tuberculosis |
2.0% |
Premedication |
1.8% |
Colorectal Cancer |
1.7% |
Oesophageal Carcinoma |
1.6% |
Multiple Sclerosis |
1.5% |
Diabetes Mellitus |
1.5% |
Convulsion |
1.4% |
Colon Cancer |
1.4% |
Medical Diet |
1.4% |
Non-small Cell Lung Cancer |
1.4% |
|
Vomiting |
13.8% |
Weight Decreased |
11.9% |
Nephrolithiasis |
5.7% |
Weight Increased |
5.7% |
White Blood Cell Count Decreased |
5.7% |
Muscular Weakness |
4.8% |
Pruritus |
4.8% |
Renal Failure Acute |
4.8% |
Wheezing |
4.8% |
Sepsis |
4.3% |
Urticaria |
4.3% |
Flushing |
3.8% |
Pyrexia |
3.8% |
Respiratory Failure |
3.8% |
Death |
3.3% |
Thrombocytopenia |
3.3% |
Diarrhoea |
2.9% |
Disseminated Intravascular Coagulation |
2.9% |
Dyspnoea |
2.9% |
Epilepsy |
2.9% |
|
Interacting |
Bk Virus Infection |
50.0% |
Smoking Cessation Therapy |
50.0% |
|
Discomfort |
50.0% |
Nausea |
50.0% |
|